These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9135274)

  • 1. delta F508 in cystic fibrosis: willing but not able.
    Southern KW
    Arch Dis Child; 1997 Mar; 76(3):278-82. PubMed ID: 9135274
    [No Abstract]   [Full Text] [Related]  

  • 2. New therapies in cystic fibrosis.
    Ratjen F; Grasemann H
    Curr Pharm Des; 2012; 18(5):614-27. PubMed ID: 22229570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal function of the cystic fibrosis conductance regulator protein can be associated with homozygous (Delta)F508 mutation.
    Sermet-Gaudelus I; Vallée B; Urbin I; Torossi T; Marianovski R; Fajac A; Feuillet MN; Bresson JL; Lenoir G; Bernaudin JF; Edelman A
    Pediatr Res; 2002 Nov; 52(5):628-35. PubMed ID: 12409506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial cell chloride channel activity correlates with improved airway function in cystic fibrosis patients with the major mutant: Delta F508.
    Kidd JF; Bear CE
    Pediatr Res; 2002 Nov; 52(5):625-7. PubMed ID: 12409505
    [No Abstract]   [Full Text] [Related]  

  • 5. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
    French PJ; van Doorninck JH; Peters RH; Verbeek E; Ameen NA; Marino CR; de Jonge HR; Bijman J; Scholte BJ
    J Clin Invest; 1996 Sep; 98(6):1304-12. PubMed ID: 8823295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects in processing and trafficking of cystic fibrosis transmembrane conductance regulator.
    Kunzelmann K; Nitschke R
    Exp Nephrol; 2000; 8(6):332-42. PubMed ID: 11014930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis: frequency of delta f508 and g542x mutations in Cordoba, Argentina.
    Saleh MC; Botelli A; Melano de Botelli M; Rezzonico CA; Argaraña CE
    Medicina (B Aires); 1996; 56(1):14-6. PubMed ID: 8734924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frequency of delta F508 mutation in Venezuelan patients with cystic fibrosis].
    Morales-Machin A; Borjas-Fajardo L; Pineda L; González S; Delgado W; Zabala W; Fernández E
    Invest Clin; 2004 Jun; 45(2):121-30. PubMed ID: 15211979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model for the delta F508 allele of cystic fibrosis.
    Zeiher BG; Eichwald E; Zabner J; Smith JJ; Puga AP; McCray PB; Capecchi MR; Welsh MJ; Thomas KR
    J Clin Invest; 1995 Oct; 96(4):2051-64. PubMed ID: 7560099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis: a multiple exocrinopathy caused by dysfunctions in a multifunctional transport protein.
    Schwiebert EM; Benos DJ; Fuller CM
    Am J Med; 1998 Jun; 104(6):576-90. PubMed ID: 9674722
    [No Abstract]   [Full Text] [Related]  

  • 11. Cystic fibrosis transmembrane regulator potentiators as promising cystic fibrosis therapies.
    Antoniu SA
    Expert Opin Investig Drugs; 2011 Mar; 20(3):423-5. PubMed ID: 21303308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
    deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
    Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of the delta F508 CFTR mutation.
    Guggino SE
    Trends Microbiol; 1999 Feb; 7(2):55-6; discussion 56-8. PubMed ID: 10081079
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged survival of neutrophils from patients with Delta F508 CFTR mutations.
    McKeon DJ; Condliffe AM; Cowburn AS; Cadwallader KC; Farahi N; Bilton D; Chilvers ER
    Thorax; 2008 Jul; 63(7):660-1. PubMed ID: 18587042
    [No Abstract]   [Full Text] [Related]  

  • 15. What happens to deltaF508 in vivo?
    Drumm M
    J Clin Invest; 1999 May; 103(10):1369-70. PubMed ID: 10330418
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Perry LA; Penny-Dimri JC; Aslam AA; Lee TW; Southern KW
    Paediatr Respir Rev; 2017 Mar; 22():47-49. PubMed ID: 27964951
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene therapy in cystic fibrosis.
    Prickett M; Jain M
    Transl Res; 2013 Apr; 161(4):255-64. PubMed ID: 23273902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.
    Pankow S; Bamberger C; Calzolari D; Martínez-Bartolomé S; Lavallée-Adam M; Balch WE; Yates JR
    Nature; 2015 Dec; 528(7583):510-6. PubMed ID: 26618866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal screening for the cystic fibrosis main mutation delta F508 in Estonia.
    Klaassen T; Teder M; Viikmaa M; Metspalu A
    J Med Screen; 1998; 5(1):16-9. PubMed ID: 9575453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between phenotype and genotype in a group of patients with cystic fibrosis].
    Navarro H; Kolbach M; Repetto G; Guiraldes E; Harris P; Foradori A; Poggi H; Sánchez I
    Rev Med Chil; 2002 May; 130(5):475-81. PubMed ID: 12143267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.